RecruitingPhase 2NCT04375813

Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention

Studying Muscular tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Robert Svatek
Principal Investigator
Robert S Svatek, MD, MSC
The University of Texas Health Science Center at San Antonio
Intervention
eRapa(drug)
Enrollment
166 enrolled
Eligibility
18 years · All sexes
Timeline
20212026

Study locations (2)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04375813 on ClinicalTrials.gov

Other trials for Muscular tumor

Additional recruiting or active studies for the same condition.

See all trials for Muscular tumor

← Back to all trials